Clinical studies
Our well-established expertise in clinical studies serves us well when it comes to developing innovative solutions in cooperation with partners and health care professionals. From pharmaceuticals to dermo-cosmetics, improving patient health is the prime focus of all our research.
Clinical studies
Interventional clinical trials
Interventional clinical trials are designed to answer a set of essential questions, such as whether a new product is well tolerated and has positive health outcomes for the target population.
Real-world studies
Observational or ‘real-world’ studies involve observing the efficacy and tolerance of a prescribed product as part of routine medical care, used according to its indication.
Academic research projects
Pierre Fabre is committed to supporting medical and scientific research projects run by academic stakeholders that aim to improve our understanding of pathologies and address patients’ medical needs.
If you are interested in working with us, please reach out to the Pierre Fabre medical teams in your country.
Clinical trials conducted worldwide
Laboratoires Pierre Fabre conducts clinical trials worldwide to assess the tolerance and efficacy of its products. These trials are an essential part of our quest to develop innovative solutions to treat or prevent diseases.
We truly believe it is fundamental to share information about our clinical trials, for the benefit of patients as well as health workers, practitioners, the health authorities, and medical research as a whole.
Núria Pérez-Cullell
Medical Affairs and Patient & Consumer Relations Director
Laboratoires Pierre Fabre makes data from the clinical trials it sponsors available to the public, without compromising participants’ privacy, because we firmly believe that greater transparency benefits medical research, patients, and public health as a whole.
Our data transparency policy is based on five pillars:
-
All the clinical trials and real-world studies we sponsor are declared in public registries and described on the website.
-
We guarantee public access to the results of clinical trials.
-
We are committed to publishing the results of the clinical trials we sponsor in scientific journals.
-
All our clinical study reports are available, along with any documents required for marketing authorization applications in Europe since January 2014.
-
We promote responsible sharing of data with researchers.
